Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
69 hedge funds and large institutions have $33.4M invested in Spectrum Pharmaceuticals Inc in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 9 closing their positions.
304% more call options, than puts
Call options by funds: $457K | Put options by funds: $113K
100% more capital invested
Capital invested by funds: $16.7M → $33.4M (+$16.8M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
0% more funds holding
Funds holding: 69 → 69 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$467K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$275K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$179K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$114K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$396K |
| 2 |
Millennium Management
New York
|
-$385K |
| 3 |
BlackRock
New York
|
-$311K |
| 4 |
AC
Armistice Capital
New York
|
-$219K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$216K |
SPPI Hedge Fund Activity: Q1 2023 in Review
69 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2023, worth a combined $33.4M — up 100% from $16.7M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SPPI positions and 9 closed out — a net gain of 1 holder — while 17 added to existing stakes and 16 trimmed.
The largest buyer was Sargent Investment Group, adding an estimated $467K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $396K sold.
- 69 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $33.4M of Spectrum Pharmaceuticals Inc stock for Q1 2023, up 100% quarter-over-quarter.
- 10 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2023 and 9 closed out, a net change of +1 holder.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2023 was Sargent Investment Group, an estimated $467K added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2023 was D.E. Shaw & Co, an estimated $396K sold.
Based on aggregated 13F filings for Q1 2023.